(Press-News.org) LA JOLLA, Calif., September 25 2013 – A new experimental approach to treating a type of brain cancer called medulloblastoma has been developed by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham). The method targets cancer stem cells—the cells that are critical for maintaining tumor growth—and halts their ability to proliferate by inhibiting enzymes that are essential for tumor progression. The process destroys the ability of the cancer cells to grow and divide, paving the way for a new type of treatment for patients with this disease.
The research team, led by Robert Wechsler-Reya, Ph.D., professor in Sanford-Burnham's NCI-Designated Cancer Center and director of the Tumor Initiation and Maintenance Program, discovered that the medulloblastoma cancer cells responsible for tumor growth and progression (called cancer stem cells or tumor-propagating cells—TPCs) divide more quickly than normal cells. Correspondingly, they have higher levels of certain enzymes that regulate the cell cycle (Aurora and Polo-like kinases). By using small-molecule inhibitors to stop the action of these enzymes, the researchers were able to block the growth of tumor cells from mice as well as humans. The research findings are described in an online paper published September 25 by Cancer Research.
"One tumor can have many different types of cells in it, and they can grow at different rates. By targeting fast-growing TPCs with cell-cycle inhibitors, we have developed a new route to assault medulloblastoma. In this study, we have shown that cell-cycle inhibitors essentially block medulloblastoma tumor progression by halting TPC expansion, and have opened the window to preventing cancer recurrence," said Wechsler-Reya.
For their research, the scientists tested the effectiveness of cell-cycle inhibitors in a specific type of brain cancer called Sonic Hedgehog (SHH)-associated medulloblastoma. These cancers have mutations in components of the SHH pathway that regulate cell growth during normal development. The mutations cause cell signaling to go awry, triggering the creation of cancer cells that grow uncontrollably and establish tumors. SHH-associated tumors account for 25 percent of all human cases of medulloblastoma, and the SHH pathway has been implicated in other tumor types such as lung, breast, prostate, and skin cancer.
"Our increased understanding of SHH-associated tumors has recently led to the development of drugs that specifically inhibit the SHH pathway. Early studies in humans with these new drugs have offered some hope for patients, but many do not respond and most patients who do respond develop resistance to the drug. For this reason, it is essential to develop alternative, or additional, therapies that are more effective than current treatment options," Wechsler-Reya said.
The team's first set of experiments used a mouse model for SHH-dependent medulloblastoma. In-vitro studies of mouse tumor cells showed that cell-cycle inhibitors caused tumor cell death. In vivo, mice that were treated with the inhibitor had smaller tumors that weighed less compared to mice that were not treated, essentially halting the progression of the tumor.
The second set of experiments used human SHH-dependent medulloblastoma cells. When the researchers treated these human tumor cells with cell-cycle inhibitors, they also observed a significant reduction in tumor growth and progression.
Finally, when the scientists combined SHH inhibitors with cell-cycle inhibitors, they found that the combination worked together to produce results that were greater than either inhibitor alone.
"These results strongly support an approach to treatment that combines SHH inhibitors with cell-cycle inhibitors to treat medulloblastoma. Our hope is that the combination of these inhibitors will prevent tumor progression and drug resistance, and improve the overall effectiveness of current treatment options. We look forward to clinical studies in human medulloblastoma patients as well as other cancers that are suitable for this approach," Wechsler-Reya said.
###
This research was funded by the National Cancer Institute (grant ROI-CA122759) and the National Institute for Neurological Diseases and Stroke (ROI NSO52323) as well as pilot funds from Golfers Against Cancer and the Pediatric Brain Tumor Foundation Institute at Duke University. R.J. Wechsler-Reya is the recipient of a Leadership Award (CIRM LA-01747) from the California Institute for Regenerative Medicine (San Francisco, Calif.).
The study was co-authored by Shirley L. Markant, Sanford-Burnham, Sanford Consortium for Regenerative Medicine, and Duke University Medical Center; Lourdes A. Esparza, Sanford-Burnham and Sanford Consortium for Regenerative Medicine; Jesse Sun, Duke University Medical Center; Kelly L. Barton, Duke University Medical Center; Lisa M. McCoig, Duke University Medical Center; Gerald A. Grant, Duke University Medical Center, John R. Crawford, University of California San Diego and Rady Children's Hospital, San Diego; Michael L. Levy, University of California San Diego and Rady Children's Hospital, San Diego; Paul A. Northcott, German Cancer Research Center, Heidelberg, Germany and Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; David Shih, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Marc Remke, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Michael Dr. Taylor, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; and Robert J. Wechsler-Reya, Sanford-Burnham, Sanford Consortium for Regenerative Medicine, and Duke University Medical Center.
About Medulloblastoma
Medulloblastoma is the most common malignant brain tumor, affecting about 500 children under the age of 10 in the United States annually. Current treatment options for medulloblastoma include aggressive surgery, radiation, and chemotherapy. Today, over two-thirds of children are successfully treated. However, survivors generally suffer long-term side effects such as cognitive and developmental disabilities due to the aggressive treatment, and in many cases the tumor reappears within two years after treatment.
About Sanford-Burnham Medical Research Institute
Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham takes a collaborative approach to medical research with major programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is recognized for its National Cancer Institute-designated Cancer Center and expertise in drug discovery and stem-cell technologies. Sanford-Burnham is a nonprofit, independent institute that employs 1,200 scientists and staff in San Diego (La Jolla), California, and Orlando (Lake Nona), Florida. For more information, visit us at sanfordburnham.org.
New approach to treating human brain cancer could lead to improved outcomes
Disrupting cancer stem cells in medulloblastoma blocks cell division, induces cell death, and overcomes tumors resistant to therapy. Targeting the cell-division cycle may lead to improved outcomes for patients with this highly malignant cancer
2013-09-25
ELSE PRESS RELEASES FROM THIS DATE:
Genetic makeup and diet interact with the microbiome to impact health
2013-09-25
ROCHESTER, Minn . -- A Mayo Clinic researcher, along with his collaborators, has shown that an individual's genomic makeup and diet interact to determine which microbes exist and how they act in the host intestine. The study was modeled in germ-free knockout mice to mimic a genetic condition that affects 1 in 5 humans and increases the risk for digestive diseases. The findings appear in the Proceedings of the National Academy of Sciences.
"Our data show that factors in the differences in a host's genetic makeup -- in this case genes that affect carbohydrates in the gut ...
Researchers develop model to study human response to infections that cause peptic ulcers
2013-09-25
Researchers at the Virginia Bioinformatics Institute at Virginia Tech have developed a new large animal model to study how the immune system interacts with the stomach bacterium Helicobacter pylori, the leading cause of peptic ulcer disease.
The discovery in the October edition of the journal Infection and Immunity may inform changes in the ways doctors treat patients. An estimated 4 million Americans have sores in the stomach lining known as peptic ulcers, according to the American Gastroenterological Association.
Although the bacterium is found in more than half ...
Survey reveals improving salary and employment picture for chemists
2013-09-25
With the U.S. economy slowly trudging back from recession and uncertainties remaining about government sequestration, the employment and salary snapshot for chemists and chemical engineers in 2013 shows that salaries and the job market are improving. Results of the American Chemical Society's annual survey of its members are the topic of the cover story in Chemical & Engineering News, ACS' weekly newsmagazine.
Sophie Rovner, assistant managing editor of C&EN, notes that the survey results are encouraging. Salaries and employment for chemists are on the rise. Full-time ...
Alpine archaeology reveals high life through the ages
2013-09-25
An international team of archaeologists led by experts from the University of York has uncovered evidence of human activity in the high slopes of the French Alps dating back over 8000 years.
The 14-year study in the Parc National des Eìcrins in the southern Alps is one of the most detailed archaeological investigations carried out at high altitudes. It reveals a story of human occupation and activity in one of the world's most challenging environments from the Mesolithic to the Post-Medieval period.
The work included the excavation of a series of stone animal enclosures ...
Discovery offers bio-solution to severe canola crop losses
2013-09-25
A genetic discovery by a University of Calgary-led international research team offers a solution to a long-standing "green seed problem" that causes millions of dollars annually in canola crop losses.
Led by Marcus Samuel in the Faculty of Science, researchers from the U of C, the University of Toronto and the University of Bordeaux in France, have uncovered a plant gene regulatory network that could be genetically enhanced to prevent green seeds from occurring in mature canola.
"The annual loss in North America alone is close to $150 million from this de-greening issue," ...
Dams provide resilience to Columbia River basin from climate change impacts
2013-09-25
CORVALLIS, Ore. – Dams have been vilified for detrimental effects to water quality and fish passage, but a new study suggests that these structures provide "ecological and engineering resilience" to climate change in the Columbia River basin.
The study, which was published in the Canadian journal Atmosphere-Ocean, looked at the effects of climate warming on stream flow in the headwaters and downstream reaches of seven sub-basins of the Columbia River from 1950 to 2010. The researchers found that the peak of the annual snowmelt runoff has shifted to a few days earlier, ...
Some childhood cancer survivors may face subsequent renal problems
2013-09-25
PHILADELPHIA -- Adult survivors of childhood cancers who underwent certain chemotherapy treatments or kidney surgery had worse kidney function that did not recover over time. Because of this, they may be at higher risk for premature renal failure, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
"Current knowledge suggests childhood cancer survivors (CCS) have an increased risk for impaired kidney function after specific cancer therapies; however, it was not known whether their kidney ...
Diet and exercise for knee osteoarthritis produces greater improvement in knee pain, function
2013-09-25
Among overweight and obese adults with knee osteoarthritis, combining intensive diet and exercise led to less knee pain and better function after 18 months than diet-alone and exercise-alone, according to a study in the September 25 issue of JAMA.
"Osteoarthritis (OA) is the leading cause of chronic disability among older adults. Knee OA is the most frequent cause of mobility dependency and diminished quality of life, and obesity is a major risk factor for knee OA. Current treatments for knee OA are inadequate; of patients treated pharmacologically, only about half experience ...
Study findings question frequency of bone mineral density testing for predicting fracture risk
2013-09-25
A second bone mineral density (BMD) screening four years after a baseline measurement provided little additional value when assessing risk for hip or other major osteoporotic fracture among older men and women untreated for osteoporosis, and resulted in little change in risk classification used in clinical management, findings that question the common clinical practice of repeating a BMD test every 2 years, according to a study in the September 25 issue of JAMA.
Bone mineral density testing is important in the management of osteoporosis. Guidelines for initiating pharmacologic ...
Sensor-augmented insulin pump therapy reduces rate of severe hypoglycemic events
2013-09-25
Use of an insulin pump with a sensor that suspends insulin delivery when blood glucose falls below a set threshold reduced the rate of severe and moderate hypoglycemia among patients with type 1 diabetes and impaired awareness of hypoglycemia, according to a study in the September 25 issue of JAMA.
Hypoglycemia is a critical obstacle to the care of patients with type 1 diabetes. Sensor-augmented pump therapy with an automated insulin suspension or low glucose suspension function is a technology has the potential to reduce the duration and frequency of significant hypoglycemia, ...
LAST 30 PRESS RELEASES:
Twelve questions to ask your doctor for better brain health in the new year
Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes
Study identifies genetic cause for yellow nail syndrome
New drug to prevent migraine may start working right away
Good news for people with MS: COVID-19 infection not tied to worsening symptoms
Department of Energy announces $179 million for Microelectronics Science Research Centers
Human-related activities continue to threaten global climate and productivity
Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued
Unraveling the power and influence of language
Gene editing tool reduces Alzheimer’s plaque precursor in mice
TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies
Twisted Edison: Bright, elliptically polarized incandescent light
Structural cell protein also directly regulates gene transcription
Breaking boundaries: Researchers isolate quantum coherence in classical light systems
Brain map clarifies neuronal connectivity behind motor function
Researchers find compromised indoor air in homes following Marshall Fire
Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality
Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology
'Glass fences' hinder Japanese female faculty in international research, study finds
Vector winds forecast by numerical weather prediction models still in need of optimization
New research identifies key cellular mechanism driving Alzheimer’s disease
Trends in buprenorphine dispensing among adolescents and young adults in the US
Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility
Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity
Association of state cannabis legalization with cannabis use disorder and cannabis poisoning
Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders
Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals
Unlocking the mysteries of the human gut
High-quality nanodiamonds for bioimaging and quantum sensing applications
New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia
[Press-News.org] New approach to treating human brain cancer could lead to improved outcomesDisrupting cancer stem cells in medulloblastoma blocks cell division, induces cell death, and overcomes tumors resistant to therapy. Targeting the cell-division cycle may lead to improved outcomes for patients with this highly malignant cancer